FindTrial
Sign In

comparing 3 drugs delivered via mucosal atomiser device for painless bronchoscopy in patients with lung infection

Randomised comparative study between atomised intranasal dexmedetomidine , lignocaine and ketamine as premedication for flexible fibreoptic bronchoscopy - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093079
Enrollment
60
Registered
2025-08-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J22- Unspecified acute lower respiratory infection

Interventions

Intervention1: Dexmedetomedine: 2 mcg/kg intranasal dexmedetomedine will be given through atomizer on deep inhalation, 30 minutes prior to procedure Intervention2: Ketamine: 2mg/kg intranasal ketamine

Sponsors

ESIC MEDICAL COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA I & II patients, age older than 18 years, BMI less than 30 kg/cm2

Exclusion criteria

Exclusion criteria: ASA III & IV patients, history of bronchial asthma, history of allergy to the study drugs

Design outcomes

Primary

MeasureTime frame
patient cough scoreTimepoint: baseline,immediately after passage of bronchoscope through vocal cords, at 5 and 10 minutes during the bronchoscopy procedure—

Secondary

MeasureTime frame
patient satisfaction scoreTimepoint: 10 minutes after end of procedure;ramsay sedation scoreTimepoint: prior to procedure, 10 minutes after end of proceure;endoscopists satisfaction scoreTimepoint: after end of procedure;rescue lignocaine requiredTimepoint: during procedure—

Countries

India

Contacts

Public ContactPrerna Bhola

ESIC MEDICAL COLLEGE

niraananya@gmail.com08179654082

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026